|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 3679141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18867097.0 |
| Date of filing the European patent application | 2018-10-12 | |
| (97) | Date of publication of the European application | 2020-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/055735 |
| Date | 2018-10-12 |
| (87) | Number | WO 2019/075419 |
| Date | 2019-04-18 |
| (30) | Number | Date | Country code |
| 201762572398 P | 2017-10-13 | US | |
| 201762572403 P | 2017-10-13 | US | |
| 201862726950 P | 2018-09-04 | US |
| (72) |
BROWN, Bob, D. , US
DUDEK, Henryk, T. , US
SAXENA, Utsav , US
PURSELL, Natalie , US
LAI, Cheng , US
WANG, Weimin , US
STORR, Rachel , US
NAZEF, Naim , US
KIM, Boyoung , US
|
| (73) |
Novo Nordisk Health Care AG ,
The Circle 32/38
8058 Zürich,
CH
|
| (54) | METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA |
| METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF LDHA |